首页 | 本学科首页   官方微博 | 高级检索  
     

靶向uPA-uPAR系统在肿瘤治疗中的研究进展
引用本文:蔡伟文,秦龙,张俊昶,文飞,张文涛,焦作义. 靶向uPA-uPAR系统在肿瘤治疗中的研究进展[J]. 肿瘤防治研究, 2023, 50(2): 202-208. DOI: 10.3971/j.issn.1000-8578.2023.22.0737
作者姓名:蔡伟文  秦龙  张俊昶  文飞  张文涛  焦作义
作者单位:1. 730000 兰州,兰州大学第二医院普通外科;2. 730000 兰州,兰州大学第二医院萃英生物医学研究中心
基金项目:甘肃省科技计划项目(21ZD4FA015);甘肃省药品科研项目(2021GSMPA007)
摘    要:uPA-uPAR系统在多种肿瘤组织中表达增高,该系统不但可促进细胞外基质蛋白降解,而且可以与玻连蛋白、整合素等结合参与细胞内信号转导,从而介导肿瘤的发生与发展。近年来,一系列靶向uPA-uPAR系统的方案在肿瘤治疗中取得了显著效果,并且其中部分药物已经进入临床试验阶段,为肿瘤的靶向治疗提供了新思路。本文拟从靶向uPA-uPAR系统的基因治疗、药物治疗和免疫治疗等方面的研究进展进行综述。

关 键 词:uPA  uPAR  PAI-1  肿瘤  靶向治疗
收稿时间:2022-07-04

Research Progress of Targeting uPA-uPAR System in Tumor Therapy
CAI Weiwen,QIN Long,ZHANG Junchang,WEN Fei,ZHANG Wentao,JIAO Zuoyi. Research Progress of Targeting uPA-uPAR System in Tumor Therapy[J]. Cancer Research on Prevention and Treatment, 2023, 50(2): 202-208. DOI: 10.3971/j.issn.1000-8578.2023.22.0737
Authors:CAI Weiwen  QIN Long  ZHANG Junchang  WEN Fei  ZHANG Wentao  JIAO Zuoyi
Affiliation:1. Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730000, China; 2. Cuiying Biomedical Research Center, Lanzhou University Second Hospital, Lanzhou 730000, China
Abstract:The uPA-uPAR system is highly expressed in various tumor tissues. This system can promote the degradation of extracellular matrix proteins, as well as combine with vitronectin and integrin to transmit intracellular signal transduction. Subsequently, it mediates the occurrence and development of tumors. In recent years, a series of therapeutic programs that target this system has achieved notable results in tumor treatment, and some of them have been under the clinical trial stage, thus providing new ideas for tumor targeted therapy. Therefore, this paper intends to provide a review of research progress on the gene therapy, drug therapy, and immunotherapy targeting uPA-uPAR system.
Keywords:uPA  uPAR  PAI-1  Tumor  Targeting therapy  
本文献已被 维普 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号